These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19586905)

  • 1. Slc4a11 gene disruption in mice: cellular targets of sensorineuronal abnormalities.
    Lopez IA; Rosenblatt MI; Kim C; Galbraith GC; Jones SM; Kao L; Newman D; Liu W; Yeh S; Pushkin A; Abuladze N; Kurtz I
    J Biol Chem; 2009 Sep; 284(39):26882-96. PubMed ID: 19586905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse Slc4a11 expressed in Xenopus oocytes is an ideally selective H+/OH- conductance pathway that is stimulated by rises in intracellular and extracellular pH.
    Myers EJ; Marshall A; Jennings ML; Parker MD
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C945-C959. PubMed ID: 27681179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assessment of SLC4A11, an integral membrane protein mutated in corneal dystrophies.
    Loganathan SK; Schneider HP; Morgan PE; Deitmer JW; Casey JR
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C735-C748. PubMed ID: 27558157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional ion transport properties of human SLC4A11: comparison of the SLC4A11-B and SLC4A11-C variants.
    Kao L; Azimov R; Shao XM; Frausto RF; Abuladze N; Newman D; Aldave AJ; Kurtz I
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C820-C830. PubMed ID: 27581649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC4A11 and the Pathophysiology of Congenital Hereditary Endothelial Dystrophy.
    Patel SP; Parker MD
    Biomed Res Int; 2015; 2015():475392. PubMed ID: 26451371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome.
    Siddiqui S; Zenteno JC; Rice A; Chacón-Camacho O; Naylor SG; Rivera-de la Parra D; Spokes DM; James N; Toomes C; Inglehearn CF; Ali M
    Cornea; 2014 Mar; 33(3):247-51. PubMed ID: 24351571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice with a targeted disruption of Slc4a11 model the progressive corneal changes of congenital hereditary endothelial dystrophy.
    Han SB; Ang HP; Poh R; Chaurasia SS; Peh G; Liu J; Tan DT; Vithana EN; Mehta JS
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6179-89. PubMed ID: 23942972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC4A11 mutations causative of congenital hereditary endothelial dystrophy (CHED) progressing to Harboyan syndrome in consanguineous Pakistani families.
    Firasat S; Dur-E-Shawar ; Khan WA; Sughra U; Nousheen ; Kaul H; Naz S; Noreen B; Gul R; Afshan K
    Mol Biol Rep; 2021 Nov; 48(11):7467-7476. PubMed ID: 34637099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borate transporter SLC4A11 mutations cause both Harboyan syndrome and non-syndromic corneal endothelial dystrophy.
    Desir J; Moya G; Reish O; Van Regemorter N; Deconinck H; David KL; Meire FM; Abramowicz MJ
    J Med Genet; 2007 May; 44(5):322-6. PubMed ID: 17220209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11.
    Chiu AM; Mandziuk JJ; Loganathan SK; Alka K; Casey JR
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7739-53. PubMed ID: 26641551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harboyan syndrome: novel SLC4A11 mutation, clinical manifestations, and outcome of corneal transplantation.
    Tananuvat N; Tananuvat R; Chartapisak W; Mahanupab P; Hokierti C; Srikummool M; Kampuansai J; Intachai W; Olsen B; Ketudat Cairns JR; Kantaputra P
    J Hum Genet; 2021 Feb; 66(2):193-203. PubMed ID: 32884076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human SLC4A11-C functions as a DIDS-stimulatable H⁺(OH⁻) permeation pathway: partial correction of R109H mutant transport.
    Kao L; Azimov R; Abuladze N; Newman D; Kurtz I
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C176-88. PubMed ID: 25394471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of phenotype-genotype correlation of patients expressing mutations in the SLC4A11 gene.
    Mehta JS; Hemadevi B; Vithana EN; Arunkumar J; Srinivasan M; Prajna V; Tan DT; Aung T; Sundaresan P
    Cornea; 2010 Mar; 29(3):302-6. PubMed ID: 20118786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R125H, W240S, C386R, and V507I SLC4A11 mutations associated with corneal endothelial dystrophy affect the transporter function but not trafficking in PS120 cells.
    Li S; Hundal KS; Chen X; Choi M; Ogando DG; Obukhov AG; Bonanno JA
    Exp Eye Res; 2019 Mar; 180():86-91. PubMed ID: 30557570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations.
    Vilas GL; Loganathan SK; Quon A; Sundaresan P; Vithana EN; Casey J
    Hum Mutat; 2012 Feb; 33(2):419-28. PubMed ID: 22072594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane water-flux through SLC4A11: a route defective in genetic corneal diseases.
    Vilas GL; Loganathan SK; Liu J; Riau AK; Young JD; Mehta JS; Vithana EN; Casey JR
    Hum Mol Genet; 2013 Nov; 22(22):4579-90. PubMed ID: 23813972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed assessment of renal function in a proband with Harboyan syndrome caused by a novel homozygous SLC4A11 nonsense mutation.
    Liskova P; Dudakova L; Tesar V; Bednarova V; Kidorova J; Jirsova K; Davidson AE; Hardcastle AJ
    Ophthalmic Res; 2015; 53(1):30-5. PubMed ID: 25500497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IPSC-Derived Corneal Endothelial-like Cells Act as an Appropriate Model System to Assess the Impact of SLC4A11 Variants on Pre-mRNA Splicing.
    Brejchova K; Dudakova L; Skalicka P; Dobrovolny R; Masek P; Putzova M; Moosajee M; Tuft SJ; Davidson AE; Liskova P
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3084-3090. PubMed ID: 31323090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular phenotype of SLC4A11 missense mutants: Setting the stage for personalized medicine in corneal dystrophies.
    Alka K; Casey JR
    Hum Mutat; 2018 May; 39(5):676-690. PubMed ID: 29327391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditionally Immortal Slc4a11-/- Mouse Corneal Endothelial Cell Line Recapitulates Disrupted Glutaminolysis Seen in Slc4a11-/- Mouse Model.
    Zhang W; Ogando DG; Kim ET; Choi MJ; Li H; Tenessen JM; Bonanno JA
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3723-3731. PubMed ID: 28738416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.